Related Experiment Video
Updated: Jul 7, 2026

08:14
Modeling Stroke in Mice: Permanent Coagulation of the Distal Middle Cerebral Artery
Published on: July 31, 2014
Rodent models of hemorrhagic stroke
D Strbian1, A Durukan, T Tatlisumak
1Department of Neurology, Helsinki University Central Hospital, Finland. Daniel.Strbian@hus.fi
Current Pharmaceutical Design
|February 22, 2008
Summary
Developing effective treatments for hemorrhagic stroke requires understanding its complex mechanisms. Animal models are crucial for studying intracerebral hemorrhage and subarachnoid hemorrhage, guiding the development of new therapies.
Area of Science:
- Neurology
- Translational Medicine
- Animal Models
Background:
- Intracerebral hemorrhage (ICH) and subarachnoid hemorrhage (SAH) result in high mortality and severe disability.
- Current treatments for ICH are lacking, and SAH therapies require significant improvement.
- Understanding pathophysiologic mechanisms is vital for developing novel therapeutic strategies for hemorrhagic stroke.
Purpose of the Study:
- To review and discuss existing rodent models of ICH and SAH.
- To compare the similarities and differences among various hemorrhagic stroke models.
- To provide insights into selecting appropriate models for research.
Main Methods:
- Literature review of established animal models for ICH and SAH.
- Comparative analysis of model characteristics, modifications, and applications.
- Discussion on the relevance of different models for clinical translation.
Main Results:
- Multiple rodent models exist, each reliably mimicking specific aspects of ICH and SAH.
- Models vary in their ability to replicate the complexity of human hemorrhagic stroke.
- Key considerations for choosing a suitable model are highlighted.
Conclusions:
- Animal models are indispensable tools for advancing the understanding and treatment of hemorrhagic stroke.
- Careful selection of appropriate models is critical for successful research and therapeutic development.
- Further research using refined models can bridge the gap between preclinical findings and clinical application.
